These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19569163)

  • 41. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
    Paterson NE; Min W; Hackett A; Lowe D; Hanania T; Caldarone B; Ghavami A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1455-64. PubMed ID: 20708056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.
    Tuan EW; Horti AG; Olson TT; Gao Y; Stockmeier CA; Al-Muhtasib N; Bowman Dalley C; Lewin AE; Wolfe BB; Sahibzada N; Xiao Y; Kellar KJ
    Mol Pharmacol; 2015 Oct; 88(4):640-9. PubMed ID: 26162864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual Nicotinic Acetylcholine Receptor α4β2 Antagonists/α7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts.
    Crestey F; Jensen AA; Soerensen C; Magnus CB; Andreasen JT; Peters GHJ; Kristensen JL
    J Med Chem; 2018 Feb; 61(4):1719-1729. PubMed ID: 29384668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinctive single-channel properties of α4β2-nicotinic acetylcholine receptor isoforms.
    Weltzin MM; George AA; Lukas RJ; Whiteaker P
    PLoS One; 2019; 14(3):e0213143. PubMed ID: 30845161
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
    Anderson DJ; Malysz J; Grønlien JH; El Kouhen R; Håkerud M; Wetterstrand C; Briggs CA; Gopalakrishnan M
    Biochem Pharmacol; 2009 Oct; 78(7):844-51. PubMed ID: 19555668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacy.
    Mazzaferro S; Gasparri F; New K; Alcaino C; Faundez M; Iturriaga Vasquez P; Vijayan R; Biggin PC; Bermudez I
    J Biol Chem; 2014 Aug; 289(31):21795-806. PubMed ID: 24936069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test.
    Andreasen JT; Nielsen EO; Redrobe JP
    Psychopharmacology (Berl); 2009 Aug; 205(3):517-28. PubMed ID: 19452140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors.
    Sippy KB; Anderson DJ; Bunnelle WH; Hutchins CW; Schrimpf MR
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1682-5. PubMed ID: 19232492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.
    Cippitelli A; Wu J; Gaiolini KA; Mercatelli D; Schoch J; Gorman M; Ramirez A; Ciccocioppo R; Khroyan TV; Yasuda D; Zaveri NT; Pascual C; Xie XS; Toll L
    Br J Pharmacol; 2015 Apr; 172(7):1834-45. PubMed ID: 25440006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain.
    Marks MJ; Wageman CR; Grady SR; Gopalakrishnan M; Briggs CA
    Biochem Pharmacol; 2009 Oct; 78(7):795-802. PubMed ID: 19481067
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
    Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
    J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.
    Matsuyama S; Matsumoto A
    J Pharmacol Sci; 2003 Oct; 93(2):180-7. PubMed ID: 14578586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis, Nicotinic Acetylcholine Receptor Binding, and in Vitro and in Vivo Pharmacological Properties of 2'-Fluoro-(substituted thiophenyl)deschloroepibatidine Analogues.
    Ondachi PW; Castro AH; Sherman B; Luetje CW; Damaj MI; Mascarella SW; Navarro HA; Carroll FI
    ACS Chem Neurosci; 2017 Jan; 8(1):115-127. PubMed ID: 27726337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Volatile anesthetic isoflurane inhibits LTP induction of hippocampal CA1 neurons through α4β2 nAChR subtype-mediated mechanisms.
    Piao MH; Liu Y; Wang YS; Qiu JP; Feng CS
    Ann Fr Anesth Reanim; 2013 Oct; 32(10):e135-41. PubMed ID: 24011619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors.
    Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A
    J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and binding studies of epibatidine analogues as ligands for the nicotinic acetylcholine receptors.
    Mu L; Drandarov K; Bisson WH; Schibig A; Wirz C; Schubiger PA; Westera G
    Eur J Med Chem; 2006 May; 41(5):640-50. PubMed ID: 16545497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. α4β2 Nicotinic receptor desensitizing compounds can decrease self-administration of cocaine and methamphetamine in rats.
    Levin ED; Rezvani AH; Wells C; Slade S; Yenugonda VM; Liu Y; Brown ML; Xiao Y; Kellar KJ
    Eur J Pharmacol; 2019 Feb; 845():1-7. PubMed ID: 30529197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.